Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Viela Bio's Pre-Tax Income for the
three
months ended in Dec. 2020 was $-33.39 Mil. Viela Bio's Revenue for the
three
months ended in Dec. 2020 was $9.34 Mil. Therefore, Viela Bio's pretax margin for the quarter that ended in Dec. 2020 was -357.64%.
The historical rank and industry rank for Viela Bio's Pretax Margin % or its related term are showing as below:
VIE'
s Pretax Margin % Range Over the Past 10 Years
Min: -1293.07 Med: -732.97 Max: -172.86
Current: -1293.07
VIE's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -152.6
vs VIE: -1293.07
Viela Bio Pretax Margin % Historical Data
The historical data trend for Viela Bio's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Viela Bio's Pretax Margin %
For the Biotechnology subindustry, Viela Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viela Bio's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viela Bio's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Viela Bio's Pretax Margin % falls into.
Viela Bio Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Viela Bio's Pretax Margin for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viela Bio (NAS:VIE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Viela Bio Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Viela Bio's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIE has been successfully added to your 